Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-040185
Filing Date
2026-04-06
Accepted
2026-04-06 09:20:35
Documents
3
Period of Report
2026-04-06

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0285169-6k_neuro.htm 6-K 11666
2 PRESS RELEASE DATED APRIL 6, 2026 ea028516901ex99-1.htm EX-99.1 15722
3 GRAPHIC ea028516901_ex99-1img1.jpg GRAPHIC 31293
  Complete submission text file 0001213900-26-040185.txt   71718
Mailing Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562
Business Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562 972-9-9531142
NeuroSense Therapeutics Ltd. (Filer) CIK: 0001875091 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41084 | Film No.: 26839734
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)